透過您的圖書館登入
IP:3.19.31.73
  • 期刊

重症後虛弱症

Intensive Care Unit Acquired Weakness

摘要


重症後虛弱症(intensive care unit-acquired weakness,ICU-AW)是病人入住加護病房後常見的問題,本文透過系統性文獻的整理,介紹重症後虛弱症的定義、致病機轉、危險因子、評估與診斷、以及預防和治療方式。重症後虛弱症是指除了重症疾病之外,找不到其他會造成病人無力的原因,即為重症後虛弱症;其發生率高,不僅直接影響病人活動功能,也造成呼吸器脫離困難,影響生活品質;致病機轉包括發炎反應導致微循環功能失常、藥物使用、代謝改變致血糖增高、以及臥床不動;造成重症後虛弱症的危險因子包括全身性發炎反應、敗血症、多重器官衰竭、高血糖、類固醇和肌肉鬆弛藥物使用、以及臥床不動;重症後虛弱症的評估診斷可以透過理學檢查、電生理檢查、呼吸參數及生物標記等來確認;而要預防及治療重症後虛弱症,應積極治療敗血症、控制血糖、謹慎使用類固醇、避免使用肌肉鬆弛劑過久、盡早執行復健活動等。重症後虛弱症是臨床重要的議題,透過團隊的合作,盡早執行復健活動計畫,可以減少重症後虛弱症的發生及其對病人短期和長期之影響。

並列摘要


Intensive care unit-acquired weakness (ICU-AW) is a common condition in critically ill. This article introduces the definition, pathophysiology, risk factors, assessment and diagnosis, prevention and treatment of ICU-AW through systematic literature review. ICU-AW refers to the fact that in addition to severe diseases, there is no other reason for the patient's weakness; its high incidence, not only directly affects the patient's physical activity, but it also causes difficulty in ventilator weaning and quality of life. Pathophysiological mechanism of ICU-AW includes inflammatory reaction leading to microcirculatory dysfunction, medication, metabolic change leading to hyperglycemia, and bed rest, so risk factors for ICU-AW were systemic inflammatory response, sepsis, multiple organ failure, hyperglycemia, corticosteroids and neuromuscular blocking agents use, and bed rest. ICU-AW can be diagnosed by physical examination, electrophysiological examination, respiratory parameters and biomarkers. To prevent and treat ICU-AW, we should actively treat sepsis and control blood sugar, exposure to corticosteroids limited, shorten administration time of neuromuscular blocking agents, and implement early rehabilitation. ICU-AW is a clinically important issue. Through the cooperation of multidisciplinary team and early implementation of rehabilitation program the incidence of ICU-AW and its short-term and long-term impacts on patients can be reduced.

參考文獻


Witteveen E, Wieske L, Sommers J: Early prediction of intensive care unit- acquired weakness: a multicenter external validation study. J Intensive Care Med 2018: 885066618771001.
Fan E, Dowdy DW, Colantuoni E, et al: Physical complications in acute lung injury survivors: a 2-year longitudinal prospective study. Crit Care Med 2014;42:849-59.
Batt J, dos Santos CC, Cameron JI, et al: Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 2013;187:238-46.
Thomas S, Mehrholz J: Health-related quality of life, participation, and physical and cognitive function of patients with intensive care unit-acquired muscle weakness 1 year after rehabilitation in Germany: the GymNAST cohort study. BMJ Open 2018;8:e020163.
MacFarlane IA, Rosenthal FD: Severe myopathy after status asthmaticus. Lancet 1977;17:615.

延伸閱讀


國際替代計量